or Try an Advanced Search...

    Technical Analysis for IGMS - IGM Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 9.10 -6.81% -0.67
    IGMS closed up 2.36 percent on Wednesday, November 20, 2024, on 60 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IGMS trend table...
    Date Alert Name Type % Chg
    Multiple of Ten Bearish Other -6.81%
    Wide Bands Range Expansion -6.81%
    Oversold Stochastic Weakness -6.81%
    Bullish Engulfing Bullish -4.61%
    NR7 Range Contraction -4.61%
    Narrow Range Bar Range Contraction -4.61%
    Lower Bollinger Band Walk Weakness -4.61%
    Wide Bands Range Expansion -4.61%
    Oversold Stochastic Weakness -4.61%
    Hammer Candlestick Bullish -1.30%
    Older End-of-Day Signals for IGMS ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 1 hour ago
    Down 3% about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 2 % about 1 hour ago
    Down 1% about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IGMS Chart by TradingView
    Basic chart:

    Profile

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering

    Is IGMS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 10 IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 8 IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates
    Nov 8 IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M
    Nov 8 IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 7 IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans
    Nov 4 IGM Biosciences to Present at Three Upcoming Investor Conferences
    Oct 1 IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
    Oct 1 IGM Biosciences downgraded to Hold, stock falls
    Oct 1 These Stocks Are Moving the Most Today: Boeing, Super Micro, HP Inc., CVS, Ford, NIO, IGM Biosciences, and More
    Oct 1 Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
    See more IGMS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.5
    52 Week Low 4.72
    Average Volume 340,470
    200-Day Moving Average 11.08
    50-Day Moving Average 14.80
    20-Day Moving Average 13.79
    10-Day Moving Average 11.09
    Average True Range 1.54
    RSI (14) 31.51
    ADX 27.95
    +DI 14.86
    -DI 29.52
    Chandelier Exit (Long, 3 ATRs) 15.73
    Chandelier Exit (Short, 3 ATRs) 13.20
    Upper Bollinger Bands 19.85
    Lower Bollinger Band 7.72
    Percent B (%b) 0.17
    BandWidth 88.01
    MACD Line -1.58
    MACD Signal Line -0.97
    MACD Histogram -0.6116
    Fundamentals Value
    Market Cap 321.21 Million
    Num Shares 32.9 Million
    EPS -4.90
    Price-to-Earnings (P/E) Ratio -1.99
    Price-to-Sales 408.54
    Price-to-Book 3.34
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.03
    Resistance 3 (R3) 11.00 10.54 10.82
    Resistance 2 (R2) 10.54 10.21 10.56 10.75
    Resistance 1 (R1) 10.15 10.01 10.34 10.19 10.68
    Pivot Point 9.69 9.69 9.79 9.71 9.69
    Support 1 (S1) 9.30 9.37 9.50 9.34 8.85
    Support 2 (S2) 8.84 9.17 8.86 8.78
    Support 3 (S3) 8.46 8.84 8.71
    Support 4 (S4) 8.50